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Abstract
The present study evaluated the effect of different levels of energy restriction on metabolic parameters in obese ponies. Relative weight
changes, markers of lipid metabolism and oxidant/antioxidant balance were monitored. A total of eighteen obese (body condition score
$7/9) Shetland ponies were studied over a 23·5-week trial, which was divided into three periods. The first period involved a 4-week
adaptation period in which each animal was fed 100 % of their maintenance energy requirements needed to maintain a stable obese
body weight (MERob). This was followed by a 16·5-week weight-loss period in which ponies were assigned to receive either 100 %
(control group, CONTROL), 80 % (slow weight-loss (SLOW) group) or 60 % (rapid weight-loss (RAPID) group) of their MERob. During
the 3-week end-phase period, all ponies were again fed 100 % of their MERob. Relative weight loss was higher in the RAPID group
(P,0·001) compared with the SLOW group. No linear relationship was found as a doubling of the percentage of energy restriction was
accompanied by a tripling of the percentage of weight loss. Relative weight gain afterwards in the end-phase period was higher in the
RAPID group (P,0·001) compared with the SLOW and CONTROL groups. During the weight-loss period, TAG and NEFA concentrations
were highest in the RAPID group, as were a-tocopherol and ferric-reducing ability of plasma concentrations. After 8 weeks of weight loss,
the concentrations of advanced oxidation protein products were higher in the RAPID group compared with the SLOW and CONTROL
groups (P,0·001). In conclusion, the level of energy restriction influences the extent of changes in oxidant/antioxidant balance.
Practically, more severe energy restriction regimens may be associated with a greater regain of weight after the restriction period.
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With a prevalence of 19–45 %, overweight and obese horses
have become a major welfare problem in modern horse
management in developed countries(1,2). Obesity is associated
in particular with an increased risk of insulin resistance as well
as laminitis(3–5). While preventing animals from becoming
obese is the preferred route, given the current scale of this
problem, effective safe weight-loss protocols are required
especially for the laminitic pony for which increased physical
activity may be contraindicated(6). Recently, several equine
studies have been published looking at the efficacy of
weight-loss programmes with and without exercise(7–9).
Most recently, the concept of weight-loss resistance in the
horse has been highlighted with the suggestion that whereas
some animals may respond to moderate energy restriction
(low-energy food intake restricted to 1·25 % of the actual
body weight as DM intake (DMI)) with appropriate levels of
*Corresponding author: L. Bruynsteen, fax þ32 9 264 78 48, email lien.bruynsteen@ugent.be
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weight loss, others may require more marked levels of
reduction (1·00 % of body mass as daily DMI)(9). However, it
is well known that more severe energy restriction in obese
Equidae may lead to hyperlipaemia(10). In dogs, the degree
of energy restriction also affected long-term body-weight
(BW) change. A higher energy restriction resulted initially in
a greater level of weight loss, but when returned to a
‘normal’ diet, the ‘rebound’ weight gain was higher(11). This
rebound weight gain was significantly correlated with the
amount of lost BW and the level of energy restriction(11).
This effect has also been observed in patients(12).
In obese humans, oxidative stress is related to chronic
disease (e.g. hypertension, diabetes, the metabolic syndrome,
polycystic ovarian syndrome, liver disease)(13). Human obesity
increases the level of oxidative stress(14) as indicated by
increased lipid peroxidation(15,16) and decreased systemic anti-
oxidants(13,16–19). Moreover, the altered oxidant–antioxidant
status in obese children has been reported to be reversible by
a dietary restriction–weight-loss programme(19,20). Restricted
energy intake has been shown to reduce oxidative damage
to proteins, lipids and DNA in rodents(21). It has also been
shown to reduce serum advanced glycation end-product
formation in healthy and overweight or obese human adults(22).
In horses, oxidative stress has been associated with several
disorders such as recurrent airway obstruction(23,24), joint
disease(25), neurological disorders(26) and perfusion-related
disorders(27). Laminitis can be classified under this last condition.
Equine digital laminae have relatively limited superoxide
dismutase (SOD) capacity, which may make this tissue more
susceptible to damage by reactive oxygen species, such as
superoxide anion(28). However, insulin-induced laminitis has
been associated with the accumulation of advanced glycation
end products in the lamellar tissues of horses(29). Insulin resist-
ance, together with general obesity, regional accumulations
of fat tissue and hyperleptinaemia are features of equine meta-
bolic syndrome(4). Higher concentrations of plasma advanced
glycation end products, especially pentosidine (PENT), have
been found in ponies exhibiting clinical features of equine
metabolic syndrome and with a recent history of laminitis or
a current episode of laminitis compared with ponies with no
recent history of laminitis(30). Lower antioxidant capacity, as
measured by decreased erythrocyte glutathione peroxidase
activities, has also been reported in obese horses(31).
In Equidae, little is known about the effect of weight-
reduction programmes on the oxidant–antioxidant status.
Therefore, the aim of the present study was to evaluate the
effect of different levels of energy restriction on weight loss
and subsequent rebound weight gain, as well as oxidant–
antioxidant balance. It was hypothesised that greater energy
restriction would result in more weight loss, accompanied by
an improved oxidant–antioxidant balance (increased anti-
oxidant defence and decreased levels of oxidant markers).
A second hypothesis was that a more rapid weight loss
would be accompanied by a greater weight gain when the
ponies were fed again at maintenance energy levels.
Materials and methods
Animals and husbandry
A total of eighteen obese (body condition score $7/9)(32)
Shetlandgeldings, aged9·3 (SEM 3·9) years (Table1),were studied
over a 23·5-week period (August to January). Only the ponies in
good health and dental status were selected. No prior history
of clinical lameness and laminitis was reported for the ponies
included in the present study. In accordance with the range
reported by Treiber et al.(33) (7·32–242·40 pmol/l; 1·22–
40·40mU/l), baseline insulin concentrations at the start of the
adaptation period and the weight-loss period were normal
(range 33·00–237·60 pmol/l; 5·5–39·6mU/l). As the aim of the
present study was not to evaluate the effect of weight loss on
glucose and insulin dynamics, glucose tolerance tests were not
implemented. Routine foot care, vaccination and anthelmintic
treatments were undertaken before and, if necessary, during
the study. The ponies were housed individually during feeding
times in nine indoor boxes of 9m2 or in nine stalls with an
indoor and outdoor unit with a combined area of 13·83m2.
During the rest of the day, the ponies were group-housed in a
large barn (inner part 285m2; outer part 275·5m2). On the floor
of the barn, rubber mats were placed as bedding material.
Water was freely available at all times. The study design was
approved by the Ethical Committee of the Faculty of Veterinary
Medicine, Ghent University (EC2011/098). All ponies remained
healthy and no clinical abnormalities were observed.
Study design
Before the start of the adaptation period, the ponies were
given ad libitum access to the same low-energy hay (Table 2)
as that fed during the trial, for 1 month. The ponies also
Table 1. Phenotypic summary of each study group of obese ponies at the beginning of the weight-loss period
(Mean values with their standard errors)
Age (years) BW (kg)
Percentage of
overweight based
on estimated
ideal BW BCS (1–9)
Groups Mean SEM Mean SEM Mean SEM Mean SEM
CONTROL 9·7 1·9 140·8 39·8 26·4 3·6 8·3 0·3
SLOW 9·0 1·5 170·3 38·0 28·0 4·0 8·2 0·3
RAPID 9·3 1·7 154·1 25·6 27·4 6·4 8·3 0·3
BW, body weight; BCS, body condition score; SLOW, slow weight loss; RAPID, rapid weight loss.
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received the same vitamin, protein and mineral supplement
(Spillers Gro ’N Winw; MARS Horsecare; Table 2) as that fed
during the trial. The trial itself was divided into three periods:
an adaptation period of 4 weeks; a weight-loss period of
16·5 weeks; an end-phase period of 3 weeks (Table 3).
During the adaptation period, the maintenance energy
requirements to maintain a stable obese body weight
(MERob) were determined for each pony individually.
Initially, the low-energy hay was fed to provide 121 % of
maintenance net energy requirements as described by Van
Weyenberg et al.(34), based on their actual obese BW. The
ponies also received a protein–vitamin–mineral balancer
at an amount of approximately 1·32 g/kg ideal BW daily.
This amount of the balancer is similar to 12·5 % of their main-
tenance digestible energy requirements for (estimated) ideal
BW (according to National Research Council recommen-
dations)(35) and corrected for all possible vitamin and protein
insufficiencies from the hay diet. During the adaptation
period, BW was measured three times per week and based
on these measurements, changes in the amount of hay fed
were made to maintain a stable obese BW. At the end of the
last week of the adaptation period, individual MERob (100 %
iMERob) could be determined for each animal.
In the following weight-loss period, the ponies were
divided into three groups, stratified for a balanced distribution
according to age and body condition score. Age was taken
into account because concentrations of plasma protein
advanced glycation end products, especially PENT, increases
in horses during ageing(36). The control group (CONTROL)
received 100 % of their iMERob during this entire period.
The ‘slow’ weight-loss (SLOW) group was fed 80 % of their
iMERob. The ‘rapid’ weight-loss (RAPID) group was restricted
to 60 % of their iMERob.
During the end-phase period, all ponies were again fed
100 % of their original iMERob, which were determined at
the end of the adaptation period, for another 3 weeks.
Throughout the study, daily hay rations were equally divided
between two meals (09.00 and 15.00 hours) and provided in
small-holed haylage nets to maximise the time spent foraging.
The balancer was only offered during the morning feeding.
Determination of body weight
During the adaptation period and the end-phase period, ponies
were weighed (^0·1 kg) three times per week between 08.00
and 09.00 hours. During the weight-loss period, the ponies
were weighed between 08.00 and 09.00 hours on the 1st day
of each week. All measurements were recorded on a cali-
brated scale (error ^0·01 kg, serial no. 137; Bascules Robbe).
Blood sampling
Blood sampling was undertaken in the early morning before
feeding. During the weight-loss period, blood samples were
drawn every week on Monday into Vacuettew tubes (Z Serum
Clot Activator, 4ml; Greiner Bio-one) in order to determine the
concentrations of TAG and NEFA. In weeks 1, 5, 9, 13, 17, 21·5
and 24·5, blood samples were also taken for the analysis of
glucose (Vacuettew tube, FXSodiumFluoride/PotassiumOxalate,
2ml; Greiner Bio-one) and insulin, ferric-reducing ability of
plasma (FRAP), thiobarbituric acid-reactive substance (TBARS),
SOD, a-tocopherol and leptin concentrations (Vacuettew tube,
Z Serum Clot Activator, 9ml). Heparin plasma (Vacuettew tube,
LH Lithium Heparin, 9ml) was collected every 8 weeks for the
subsequent analysis of protein, advanced glycation end
Table 2. Analysed (hay) and labelled (supplement) nutrient compo-
sitions of the hay and supplement
(Spillers Gro ’N Winw, MARS Horsecare) on a DM basis
Nutrients Hay Supplement
DM (g/kg) 885 888·1
Crude protein (g/kg) 89·3 360·3
Crude ash (g/kg) 63·3 168·9
Crude fibre (g/kg) 371·8 56·3
Crude fat (g/kg) 14·7 NI
Starch (g/kg) 12·4 56·3
a-Tocopherol (mg/kg) 17·5 1688·9
DE (MJ/kg) 8·1 13·5
NI, not indicated on the label; DE, digestible energy.
Table 3. Energy intake during the adaptation period, weight-loss period and end-phase period in obese ponies*
(Mean values with their standard errors)
Adaptation period and end-phase period Weight-loss period
Energy intake
(% of iMERob)
Energy intake
(MJ/kg BW†)
Percentage of
offered hay
consumed
Energy intake
(% of iMERob)
Energy intake
(MJ/kg BW*)
Percentage of
offered hay
consumed
Groups Mean Mean SEM Mean SEM Mean Mean SEM Mean SEM
CONTROL 100 0·17 0·01 97·50 1·45 100 0·17 0·01 99·63 0·31
SLOW 100 0·17 0·01 99·84 0·21 80 0·14 0·00 99·21 1·42
RAPID 100 0·17 0·01 99·98 0·06 60 0·10 0·01 98·80 1·7
iMERob, individual maintenance energy requirements to maintain a stable obese body weight; BW, body weight; SLOW, slow weight loss; RAPID, rapid weight loss.
* Individual maintenance requirements to maintain a stable obese body weight were determined during the adaptation period. During the weight-loss period, ponies were
divided into three treatment groups (n 6): the CONTROL group, which received 100 % of their individual maintenance requirements to maintain a stable obese body weight;
the SLOW group, which received 80 % of their individual maintenance requirements to maintain a stable obese body weight; the RAPID group, which received 60 % of their
individual maintenance requirements to maintain a stable obese body weight. Energy intake was calculated as digestible energy.
† BW at the end of the adaptation period.
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products (PENT and carboxymethyllysine (CML)) and advanced
oxidation protein products (AOPP). The blood samples were
stored at 48C until centrifugation at 3000 g for 10 min. Sub-
sequently, plasma and serum samples were stored at 2208C
until analysis.
Measurements of plasma glucose and serum insulin
concentrations
Fasting plasma glucose concentrations were measured by
the enzymatic colorimetric assay method (REF 3L82-21 and
3L82-41) using an Abbott Architect C16000 autoanalyser
(Abbott Diagnostic Laboratories) with the hexokinase–glucose-
6-phosphate dehydrogenase method(37,38).
Serum insulin concentrations were measured immuno-
radiometrically(34,38) (insulin immunoradiometric assay (IRMA)
reference no. 5251; DIAsource Europe S.A.). An implemen-
tation and validation procedure has previously been described
briefly by Bruynsteen et al.(38).
Measurements of lipid metabolism markers
Serum TAG concentrations were measured enzymatically
(REF 7D74 304706/R02) using an Abbott Architect C16000
autoanalyser (Abbott Diagnostic Laboratories). Serum NEFA
concentrations were measured by the Randox NEFA kit
(REF FA 115; Randox Laboratories Limited) with modifications
for use in the Daytona System (Randox Laboratories Limited).
Measurements of antioxidant status markers
FRAP was determined by spectrophotometric analysis
(Monarch Chemistry System; Instrumentation Laboratories),
as described by Benzie & Strain(39) and previously validated
in horses by Balogh et al.(40). In this assay, antioxidant
activity was measured via the reduction of the ferric tripyridyl
triazine complex to the ferrous form at low pH, which
was monitored by measuring the change in absorption at
593 nm. Results are reported as the concentration of Fe2þ
measured per litre of serum (mmol/l). SOD concentrations
were measured with a commercially available assay kit (REF
19 160 SOD determination kit; Sigma-Aldrich), based on the
colorimetric reaction between water-soluble tetrazolium salt
and superoxide anion. Absorbance was read at 450 nm with
the Victor 3 plate reader (Perkin-Elmer). a-Tocopherol con-
centrations were determined by reversed-phase HPLC and
spectrophotometric UV detection. The reversed-phase HPLC
analytical column was a Prontosil 120-3-C18 (particle size
3mm and length 100 mm; Thermo Fisher Scientific, Inc.),
and UV detection was determined at an absorbance of
295 nm (UV2000, Thermo Fisher Scientific, Inc.).
Measurements of oxidant status markers
TBARS concentrations were measured spectrophotometrically
(Monarch Chemistry System; Instrumentation Laboratories),
as described by Lin et al.(41), and results are reported as
the concentration of malondialdehyde measured per ml
of serum (nmol/ml). Plasma protein content (protein) was
determined using the bicinchonic acid (BCA) Protein Assay
Kit (Piercew BCA Protein Assay Kit; Pierce Biotechnology),
according to the manufacturer’s instruction. PENT concen-
trations were determined by the HPLC method as described
by Valle et al.(30), with slight modifications. Chromatography
was performed using a Waters system (Waters S.P.A.)
equipped with a Bio-Tek SFM25 fluorimeter detector (Kontron
Instruments). Briefly, after delipidation with hexane and pre-
cipitation with TCA, protein content was hydrolysed with
6 M-HCl for 18 h at 1108C in borosilicate screw-capped tubes,
dried in a SpeedVace Concentrator (Thermo Fisher Scientific
Inc.), and then reconstituted in HPLC-grade water containing
0·01 M-heptafluorobutyric acid, filtered through a 0·45mm-
pore diameter Ultrafree-MC (Millipore) and injected into
an Aerise PEPTIDE XB-C18 100 reversed phase column
(250 £ 4·6 mm, 3·6mm) (Phenomenex Inc.) with a curvilinear
gradient programme of 20–40 % solvent B (methanol) for
30 min, while solvent A was water. Both water and methanol
contained 0·01 M-heptafluorobutyric acid. PENT peaks were
monitored using a fluorescent detector at an excited wave-
length of 335 nm and an emission wavelength of 385 nm. A
PENT synthetic standard (prepared as described by Grandhee
& Monnier(42)) was injected at the start of each run to deter-
mine the concentrations of PENT in the sample by comparison
of the peak area. The concentration of PENT was expressed as
pmol/mg of plasma protein content. Inter- and intra-assay
CV were 4·8 and 5·4 %, respectively. CML concentrations
were determined by the ELISA method (EIAab), according to
the manufacturer’s instructions. The detection range of the
CML ELISA kit was 0·78–58 ng/ml; therefore, plasma samples
were diluted at 1:50. Absorbance was read at 450 nm. Results
are expressed as pg/mg protein. Inter- and intra-assay CV
were 10·7 and 9·8 %, respectively. AOPP concentrations were
measured by spectrophotometry, as described previously by
Witko-Sarsat et al.(43), on a microplate reader and calibrated
with chloramine-T solutions that absorb at l ¼ 340 nm in
the presence of potassium iodide. Human serum albumin
preparation (200ml, diluted at 1:10 in PBS) was added to
the test wells of a ninety-six-well microtitre plate, followed
by the addition of acetic acid (20ml). Potassium iodide
(10ml, 1·16 mol/l) was added to the standard wells containing
chloramine-T solution (200ml, 0–100mmol/l), followed by
the addition of acetic acid (20ml). The absorbance of the reac-
tion mixture was immediately read at 340 nm against a blank
containing 200ml PBS, 10ml potassium iodide and 20ml
acetic acid. AOPP concentrations are expressed as mmol/l of
chloramine-T equivalents. The inter- and intra-assay CV were
7·2 and 6·9 %, respectively.
Measurements of serum leptin concentrations
Leptin concentrations were measured using a multispecies RIA
kit (Millipore), validated for the use in horses(44). The antibody
used was guinea pig anti-human leptin. In the absence of
purified equine leptin, results are reported as human equi-
valents of immunoreactive leptin.
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Statistical analysis
Statistical analysis was based on a linear mixed model with
pony as the random effect and treatment, time and their inter-
action as (categorical) fixed effects. A separate analysis was
carried out for the weight-loss period and the end-phase
period. Because there was a large difference in initial BW
at the start of the weight-loss period (100–243·3 kg), changes
in BW are expressed as relative differences (% change) from
the baseline value (i.e. week 5 for the weight-loss period
and week 21·5 for the end-phase period), which were used
as the response variable. Absolute values were used for the
other measured parameters. After the overall analysis, the
three treatment groups were compared pairwise at each
time point using Bonferroni’s adjustment technique for mul-
tiple comparisons. The global significance level was set at 5 %.
Results
Feed intake
The daily hay intake throughout the study is described in Table 3.
All ponies ate all of the supplement throughout the study.
The average DMI was 1·86 (SEM 0·18), 1·96 (SEM 0·15) and 1·95
(SEM 0·27)% of obese BW in the CONTROL, SLOW and RAPID
groups, respectively, at the end of the adaptation period. DMI
was 1·86 (SEM 0·18), 1·57 (SEM 0·12) and 1·17 (SEM 0·16)% of
BW in the CONTROL, SLOW and RAPID groups, respectively,
at the end of the adaptation period. During the end-phase
period, the ponies received the same DMI as that in the adap-
tation period. Energy intake from hay is described in Table 3.
Relative weight changes
During the entire weight-loss period (weeks 5–21), the
CONTROL, SLOW and RAPID groups lost an average of
0·42 (SEM 0·45), 3·59 (SEM 0·63) and 10·81 (SEM 0·77) % of
their initial BW, respectively (Fig. 1). A more rapid weight
loss was observed in the group with the highest energy
restriction (RAPID group, P,0·001); however, the relation-
ship between energy restriction and the percentage of
weight loss was not proportional as a doubling of the per-
centage of energy restriction (20 % v. 40 %) was accompanied
by a tripling of the percentage of weight loss (3·59 % v.
10·81 %).
At the end of the end-phase period, the CONTROL,
SLOW and RAPID groups had, respectively, regained 1·11
(SEM 1·64), 1·41 (SEM 1·04) and 3·40 (SEM 0·94) % of their
BW at the start of the end-phase period (week 21·5).
During the end-phase period, a treatment effect was found
between the CONTROL and RAPID groups (P,0·001), and
between the SLOW and RAPID groups (P,0·001), mean-
ing that the RAPID group gained significantly more
weight during the end-phase period than the SLOW and
CONTROL groups.
Plasma glucose and insulin concentrations
Throughout the weight-loss period, glucose concentrations
(range 3·61–5·05 mmol/l; 65–91 mg/l) changed over time
independently of the treatment (P,0·001). No significant
changes were found in the concentration of insulin during
the weight-loss period and/or the end-phase period. Mean
insulin concentrations at all time points were ,180 pmol/l
(,30 mU/l), although at the end of the weight-loss period,
two ponies had higher insulin concentrations of 453·6
pmol/l (75·6 mU/l) (CONTROL group) and 451·2 pmol/l
(75·2 mU/l) (SLOW group). At the end of the end-phase
period, another four ponies (CONTROL group, n 2; SLOW
group, n 1; RAPID group, n 1) had insulin concentrations
.30 mU/l (range 245·4–439·8 pmol/l; 40·9–73·3 mU/l).
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Fig. 1. Body-weight changes (%) in obese ponies from the control group (W), slow weight-loss group (X) and rapid weight-loss group (D) during the weight-loss
period (WLP) and end-phase period (EPP) as a proportion of the value at week 5 (beginning of the WLP). Values are means, with their standard errors rep-
resented by vertical bars. During the WLP, a significant interaction between time and treatment was observed (P,0·001). During the EPP, a group (P,0·001)
and week (P,0·001) effect was observed.
Energy restriction rate and oxidative stress 5
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
Markers of lipid metabolism
Higher and more rapid maximum TAG concentrations were
reached in the RAPID group (P¼0·001) during the first part of the
weight-loss period (Fig. 2). At the end of the end-phase period,
TAG concentrations decreased more rapidly in the RAPID group
compared with the SLOWand CONTROL groups (P,0·001).
NEFA concentrations changed during the weight-loss period
(P,0·001), with higher concentrations found in the RAPID
group compared with the SLOW and CONTROL groups
(P¼0·021). At the end of the end-phase period, NEFA con-
centrations decreased in the RAPID group, whereas the concen-
trations increased in the CONTROL group and remained stable
in the SLOW group (P¼0·014; data not shown).
Antioxidant status
FRAP concentrations changed during the weight-loss period
(P,0·001), with the highest concentrations observed in the
RAPID group (P,0·001) (Fig. 3). When comparing the end
and the beginning of the end-phase period, FRAP concen-
trations increased in the SLOW and CONTROL groups, but
remained constant in the RAPID group (P,0·001).
During the weight-loss period, SOD concentrations changed
(P¼0·036), with lower concentrations being observed in the
RAPID group after 8 weeks of weight loss (P¼0·003). SOD
concentrations increased in the three groups during the
end-phase period (P¼0·003; data not shown).
a-Tocopherol concentrations changed over time during the
weight-loss period, with the concentrations increasing in
the RAPID group but being more stable in the SLOW group
and slightly decreasing in the CONTROL group (P¼0·004;
Fig. 4) . The concentrations of a-tocopherol rapidly decreased
in the CONTROL and RAPID groups during the end-phase
period; however, a slight decrease in concentration was
observed in the SLOW group (P,0·001).
Oxidant status
During the weight-loss period and the end-phase period,
TBARS concentrations changed over time independently
of the treatment (P,0·001 and P¼0·042, respectively; data
not shown).
Throughout the weight-loss period, AOPP concentrations
changed differently over time between the three treatment
groups, with concentrations increasing in the RAPID group in
thefirst part but remaining stable in the SLOWgroup anddecreas-
ing in the CONTROL group, respectively (P¼0·015; Fig. 5) .
No significant changes were found in the concentrations of
PENT and CML.
Serum leptin concentrations
Serum leptin concentrations changed during the weight-loss
period (P¼0·002) and between the treatments (P¼0·001)
with the lowest concentrations being observed in the RAPID
group (Fig. 6). At the end of the end-phase period, leptin con-
centrations decreased most rapidly in the CONTROL group
compared with the RAPID and SLOW groups (P,0·001).
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Fig. 2. Serum TAG concentrations in obese ponies from the control group ( ), slow weight-loss group ( ) and rapid weight-loss group ( ) during the weight-loss
period (WLP) and end-phase period (EPP). Values are means, with their standard errors represented by vertical bars. During the WLP, and EPP, a significant
interaction between time and treatment was observed (P¼0·001 and P,0·001, respectively).
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Fig. 3. Serum ferric-reducing ability of plasma (FRAP) concentrations in
obese ponies from the control group ( ), slow weight-loss group ( ) and
rapid weight-loss group ( ) during the weight-loss period (WLP) and
end-phase period (EPP). Values are means, with their standard errors
represented by vertical bars. During the WLP, a significant time (P,0·001)
and treatment (P,0·001) effect was observed. During the EPP, a signi-
ficant interaction between time and treatment was observed (P,0·001).
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Discussion
To the best of our knowledge, the present study was the first
to describe the effect of different levels of energy restriction on
weight loss and oxidative stress in ponies/Equidae. In the pre-
sent study, the higher energy restriction (RAPID) was associ-
ated with the greatest weight loss, as has also been
described previously in dogs(11). A doubling of the percentage
of energy restriction was associated with a tripling of the per-
centage of weight loss (SLOW group, 3·59 % v. RAPID group,
10·81 %). However, the highest energy-restricted group
(RAPID) also showed the greatest weight gain when they
received again their 100 % iMERob, a finding similar to that
reported in dogs(11) and human subjects(12). Increased meta-
bolic efficiency, as has been reported in obesity-prone rats
after weight loss(45), could be a possible explanation, although
specific parameters (thyroid hormones, metabolic rate, indi-
vidual total and resting expenditure) were not measured
to confirm this in the present study. In obesity-prone rats,
metabolic efficiency remained elevated and contributed to a
lower energy expenditure, a greater energy imbalance, and
a higher rate of weight regain early in relapse(45). MacLean
et al.(45) reported that adjustments in appetite and resting
energy expenditure significantly contributed to the energy
imbalance when rats were given free access to a low-fat diet.
The mean weekly weight loss in the RAPID group corre-
sponded to 0·68 %, which is comparable to the losses
described in the weight-loss trial of Dugdale et al.(8) who
observed weekly weight losses of 0·7 % by feeding 1 % of
the actual BW as DMI daily in obese pony mares. In that
same study, BW decreased by 4·3 % during the 1st week of
the weight-loss period, which was attributed to decreased
gut fill and possibly the depletion of glycogen reserves associ-
ated with the transition from ad libitum food intake (positive
energy balance) to restricted food intake (negative energy bal-
ance). This phenomenon was not observed in the present
study where BW loss in the RAPID group only reached
0·87 % in the 1st week. This could possibly be attributed to
the feeding strategy during the adaptation period in the
present study, in which the ponies were fed at their MERob
instead of ad libitum food intake followed in the trial of
Dugdale et al.(8).
Leptin concentrations were lower at the end than at the
beginning of the weight-loss period, which is in accordance
with the findings reported in other weight-loss studies in
ponies(34,46). In the present study, refeeding the ponies to
100 % iMERob resulted in further lowering of leptin concen-
trations in the energy-restricted groups, which is a rather
unexpected finding as higher leptin concentrations would be
expected because of the higher energy intake and the sub-
sequent satiety effect of this hormone(47). No clear explanation
could be found for this finding.
When the body of the horse is in a state of negative energy
balance, it changes to a more catabolic state. In an attempt to
maintain normoglycaemia, there is a shift towards the use of
fatty acids as the primary energy source(10). Given the higher
predisposition of hyperlipaemia in Shetland ponies with obes-
ity as a fortifying factor(48,49), this was obviously a potential con-
cern. However, a previous study in Shetland geldings with even
more severe energy restriction (but introduced very gradually)
at 35 % of maintenance energy requirements had reported no
adverse health effects(34). In the present study, significantly
higher serum TAG and NEFA concentrations were found in
the SLOW and RAPID groups compared with the CONTROL
group, with the highest concentrations being found in the
RAPID group. However, TAG concentrations never exceeded
the upper limit of the normal range (,5000 mg/l)(10), and
none of the ponies showed any adverse clinical signs. During
the 1st weeks of the weight-loss period, accumulation of TAG
concentrations in the serum was positively associated with the
extent of weight loss. After 4 weeks of energy restriction,
even though weight loss was still continuing, TAG concen-
trations gradually returned to the baseline levels.
Together with the increase in the percentage of weight loss,
and TAG and NEFA concentrations in the blood, an increase in
plasma antioxidant capacity (as indicated by the concentrations
of a-tocopherol and FRAP) was observed during the first 4 to
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8 weeks of the study. The increase in a-tocopherol concen-
trations (as part of vitamin E) could also be attributed to the
release of this liposoluble vitamin from the fat deposit, which
is one of the major storage sites of vitamin E(50). At the end
of the weight-loss period, these concentrations returned to
the baseline levels, perhaps suggesting that the stimulus for
increased antioxidant demand had been resolved (decreased
blood TAG and NEFA concentrations). The concentration of
the pro-oxidant marker TBARS was lower at the end than at
the start of the weight-loss period, indicating that, as reported
in human subjects(13), dietary interventions resulting in even
limited weight loss may help the oxidant–antioxidant equili-
brium. The parameter TBARS has been broadly used for the
measurement of lipid peroxidation, as it is one of the better
predictors of oxidative damage(51). However, the use of this
parameter has been criticised due to its low specificity(51) and
sensitivity(52). To have a good understanding of the oxidant–
antioxidant status, multiple measures of oxidative damage
should be evaluated(27,51). Therefore, in the present study,
oxidative damage to proteins was evaluated. In humans,
lipids as well as carbohydrates are important contributors to
the chemical modification of proteins, leading to the formation
of lipoxidation products(53). The chemical modification of
amino acids in proteins during lipid peroxidation results in
the formation of lipoxidation products such as AOPP. The
higher increase in the concentration of AOPP in the RAPID
group after 8 weeks of weight loss compared with the SLOW
group could therefore be attributed to the higher TAG and
NEFA concentrations observed in the RAPID group, which are
prone to oxidation. No significant changes were observed in
the concentrations of CML and PENT, which could be due to
the tight glycaemic control in ponies and the fact that TAG
and NEFA concentrations were not high enough to form
glycoxidation and lipoxidation markers(54).
Since the diet was the main focus of the present study and
not the effect of weight loss on glucose and insulin dynamics,
no glucose tolerance tests were implemented. We should
although acknowledge that insulin resistance and hyper-
insulinaemia(55–57) are associated with oxidative stress and
therefore could be a confounding factor. However, no sig-
nificant correlations were found between plasma insulin
concentrations and TBARS, AOPP, PENT, SOD, FRAP, and
a-tocopherol concentrations.
In conclusion, different levels of energy restriction will
influence the extent of any weight loss, although there was
no apparent linear relationship between the extent of energy
restriction and the percentage of weight loss. A doubling of
the percentage of energy restriction was associated with a tri-
pling of the percentage of weight loss. Following the weight-
loss period, more extensive weight loss was associated with
more rapid and greater weight regain when ponies were fed
again at 100 % of their MERob. On the basis of the present
results, it can be recommended in practice that if the obese
equid is fed with a more severe energy-restricted diet in
order to achieve weight loss within a reasonable time
period, it is even more important that once the ideal weight
of the animal is reached, monitoring should continue in
order to avoid the rapid rebound effect of weight gain.
Finally, energy restriction and consequently weight loss
can affect the oxidant–antioxidant balance, although signi-
ficant effects were only observed in the present study
with the highest level of energy restriction. However, these
rather small effects are unlikely to be biologically significant,
and further research into the effect of weight loss on the
oxidant–antioxidant balance is warranted.
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